To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.
1 other identifier
interventional
1,000
0 countries
N/A
Brief Summary
Background Neonatal hypoglycemia is one of the most common metabolic disorders in neonatology. Maintaining stable levels of glucose in the transition from fetal life to life after birth is very important. Yet, except for the recognizing of at-risk populations, there are not many individual measures which can help and predict which newborns (from at-risk populations) will develop hypoglycemia and which will not. OBJECTIVE our objective is to try to characterize by the mother's glucose levels at birth and by umbilical cord glucose levels who would be at increased risk of hypoglycemia in the hours after birth in the population that is at increased risk of this complication in advance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Aug 2016
Typical duration for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedJuly 20, 2016
July 1, 2016
3 years
July 18, 2016
July 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Cord blood glucose levels as a predictor to newborns Hypoglycemia
Taking blood samples as a predictor to number of Hypoglycemic children.
2 weeks
Study Arms (1)
Pregnant women at risk population
EXPERIMENTALwomen who arrived to the delivery room at Lis hospital and which the newborn is about to undergo glucose levels follow-up after birth regardless the study, because of their affiliation to the at-risk population.
Interventions
After birth - taking blood sample from the umbilical cord (arterial and venous) + blood sample from the patient.
Eligibility Criteria
You may qualify if:
- Single pregnancy
- Vaginal or cesarean birth.
- Births where there is an indication of neonatal hypoglycemia follow-up - one or more of the following:
- Delivery week below 37 full weeks.
- Maternal diabetes during pregnancy (gestational diabetes or pre-gestational).
- Newborn under percentile 10 by Dolberg graph.
- Newborn above percentile 90 by Dolberg graph.
You may not qualify if:
- Multiple Pregnancy
- pregnancies in which there is no indication for routine monitoring of glucose levels after birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yariv Yogev, professor
Tel Aviv Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2016
First Posted
July 20, 2016
Study Start
August 1, 2016
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
July 20, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share